Kenji Hashimoto

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 655 publications

Is (S)-norketamine an active mediator of esketamine's antidepressant effects?

Is (S)-norketamine an active mediator of esketamine's antidepressant effects?

Journal: Molecular psychiatry

Published: June 19, 2026

Clozapine-associated pneumonia: a gut-lung-brain axis perspective.

Clozapine-associated pneumonia: a gut-lung-brain axis perspective.

Journal: European archives of psychiatry and clinical neuroscience

Published: May 16, 2026

Rethinking the Treatment-Resistant Depression.

Rethinking the Treatment-Resistant Depression.

Journal: Advances in experimental medicine and biology

Published: April 26, 2026

Exploring the lung-brain axis in perioperative neurocognitive disorders: a potential therapeutic target.

Exploring the lung-brain axis in perioperative neurocognitive disorders: a potential therapeutic target.

Journal: Molecular psychiatry

Published: April 16, 2026

Chronic stress-induced hypertension: beyond sympathetic activation to autonomic and psychiatric dysregulation.

Chronic stress-induced hypertension: beyond sympathetic activation to autonomic and psychiatric dysregulation.

Journal: Molecular psychiatry

Published: April 16, 2026

Association of baseline plasma NMDA receptor-related amino acid ratios with remission following antidepressant treatment in major depressive disorder.

Association of baseline plasma NMDA receptor-related amino acid ratios with remission following antidepressant treatment in major depressive disorder.

Journal: Journal of affective disorders

Published: March 31, 2026

PD-1/PD-L1 signaling in neurological and psychiatric disorders: neuroimmune mechanisms and therapeutic potential.

PD-1/PD-L1 signaling in neurological and psychiatric disorders: neuroimmune mechanisms and therapeutic potential.

Journal: Brain, behavior, and immunity

Published: March 31, 2026

Reconsidering the gamma-delta shift as a biomarker of antidepressant effects of ketamine enantiomers.

Reconsidering the gamma-delta shift as a biomarker of antidepressant effects of ketamine enantiomers.

Journal: British journal of pharmacology

Published: March 17, 2026

Comparative network pharmacology analysis of ketamine and xanomeline in major depressive disorder: Shared and distinct molecular mechanisms.

Comparative network pharmacology analysis of ketamine and xanomeline in major depressive disorder: Shared and distinct molecular mechanisms.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: March 14, 2026

Remote brainstem lesion associated with lower cervical spinal dural arteriovenous fistula-venous outflow bottleneck: a case report and literature review.

Remote brainstem lesion associated with lower cervical spinal dural arteriovenous fistula-venous outflow bottleneck: a case report and literature review.

Journal: Therapeutic advances in neurological disorders

Published: February 23, 2026

HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation.

HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation.

Journal: Gut microbes

Published: February 16, 2026

Sigma-1 receptor antagonism as a potential mechanism of sertraline-associated Alice in Wonderland syndrome.

Sigma-1 receptor antagonism as a potential mechanism of sertraline-associated Alice in Wonderland syndrome.

Journal: Psychiatry research

Published: February 12, 2026

Showing 1-12 of 655

Last Updated: 09/26/2026